Idecabtagene vicleucel

Status:

Do Not Prescribe (DNP)

Decision Date:

September 2022

Comments

DNP: NICE TA936 Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments - Terminated Appraisal (Decision - December 2023)

search again